CD8A and neoplasm: A hallmark of tumor cells is the evasion of this lymphocyte-induced immune attack using two main strategies: avoiding immune recognition and instigating an immunosuppressive TME, including impairing the effector functions of anti-tumor CD4+ and CD8+ T cells and promoting immunosuppressive Treg and Th17 cells [117].